Forbes & Company Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 11:30 am

Competitors of Forbes & Company Ltd

All Competitor Stocks of Forbes & Company Ltd

Quarterly Result

Last Updated: August 19, 2025, 3:29 pm

Below is a detailed analysis of the quarterly data for Forbes & Company Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 22.45 Cr.. The value appears to be declining and may need further review. It has decreased from 88.68 Cr. (Mar 2025) to 22.45 Cr., marking a decrease of 66.23 Cr..
• For Expenses, as of Jun 2025, the value is 21.30 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 77.13 Cr. (Mar 2025) to 21.30 Cr., marking a decrease of 55.83 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.15 Cr.. The value appears to be declining and may need further review. It has decreased from 11.55 Cr. (Mar 2025) to 1.15 Cr., marking a decrease of 10.40 Cr..
• For OPM %, as of Jun 2025, the value is 5.12%. The value appears to be declining and may need further review. It has decreased from 13.02% (Mar 2025) to 5.12%, marking a decrease of 7.90%.
• For Other Income, as of Jun 2025, the value is 5.34 Cr.. The value appears to be declining and may need further review. It has decreased from 97.29 Cr. (Mar 2025) to 5.34 Cr., marking a decrease of 91.95 Cr..
• For Interest, as of Jun 2025, the value is 0.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.13 Cr. (Mar 2025) to 0.16 Cr., marking an increase of 0.03 Cr..
• For Depreciation, as of Jun 2025, the value is 0.57 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.41 Cr. (Mar 2025) to 0.57 Cr., marking an increase of 0.16 Cr..
• For Profit before tax, as of Jun 2025, the value is 5.76 Cr.. The value appears to be declining and may need further review. It has decreased from 108.30 Cr. (Mar 2025) to 5.76 Cr., marking a decrease of 102.54 Cr..
• For Tax %, as of Jun 2025, the value is 15.62%. The value appears to be increasing, which may not be favorable. It has increased from 5.04% (Mar 2025) to 15.62%, marking an increase of 10.58%.
• For Net Profit, as of Jun 2025, the value is 4.86 Cr.. The value appears to be declining and may need further review. It has decreased from 102.84 Cr. (Mar 2025) to 4.86 Cr., marking a decrease of 97.98 Cr..
• For EPS in Rs, as of Jun 2025, the value is 3.77. The value appears to be declining and may need further review. It has decreased from 79.72 (Mar 2025) to 3.77, marking a decrease of 75.95.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:20 am

Growth

Last Updated: September 5, 2025, 3:30 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Forbes & Company Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 96.42. This value is within the healthy range. It has increased from -3.50 (Mar 24) to 96.42, marking an increase of 99.92.
• For Diluted EPS (Rs.), as of Mar 25, the value is 96.42. This value is within the healthy range. It has increased from -3.50 (Mar 24) to 96.42, marking an increase of 99.92.
• For Cash EPS (Rs.), as of Mar 25, the value is 97.73. This value is within the healthy range. It has increased from -0.53 (Mar 24) to 97.73, marking an increase of 98.26.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 170.16. It has increased from 60.88 (Mar 24) to 170.16, marking an increase of 109.28.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 170.16. It has increased from 60.88 (Mar 24) to 170.16, marking an increase of 109.28.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 154.46. It has increased from 97.60 (Mar 24) to 154.46, marking an increase of 56.86.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 34.16. This value is within the healthy range. It has increased from 23.06 (Mar 24) to 34.16, marking an increase of 11.10.
• For PBIT / Share (Rs.), as of Mar 25, the value is 32.94. This value is within the healthy range. It has increased from 21.79 (Mar 24) to 32.94, marking an increase of 11.15.
• For PBT / Share (Rs.), as of Mar 25, the value is 32.51. This value is within the healthy range. It has increased from 18.22 (Mar 24) to 32.51, marking an increase of 14.29.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 96.51. This value is within the healthy range. It has increased from -1.81 (Mar 24) to 96.51, marking an increase of 98.32.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 95.17. This value is within the healthy range. It has increased from -3.46 (Mar 24) to 95.17, marking an increase of 98.63.
• For PBDIT Margin (%), as of Mar 25, the value is 22.11. This value is within the healthy range. It has decreased from 23.62 (Mar 24) to 22.11, marking a decrease of 1.51.
• For PBIT Margin (%), as of Mar 25, the value is 21.32. This value exceeds the healthy maximum of 20. It has decreased from 22.32 (Mar 24) to 21.32, marking a decrease of 1.00.
• For PBT Margin (%), as of Mar 25, the value is 21.04. This value is within the healthy range. It has increased from 18.66 (Mar 24) to 21.04, marking an increase of 2.38.
• For Net Profit Margin (%), as of Mar 25, the value is 62.48. This value exceeds the healthy maximum of 10. It has increased from -1.85 (Mar 24) to 62.48, marking an increase of 64.33.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 61.61. This value exceeds the healthy maximum of 20. It has increased from -3.54 (Mar 24) to 61.61, marking an increase of 65.15.
• For Return on Networth / Equity (%), as of Mar 25, the value is 55.93. This value is within the healthy range. It has increased from -5.67 (Mar 24) to 55.93, marking an increase of 61.60.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.19. This value is within the healthy range. It has decreased from 17.86 (Mar 24) to 17.19, marking a decrease of 0.67.
• For Return On Assets (%), as of Mar 25, the value is 40.27. This value is within the healthy range. It has increased from -1.05 (Mar 24) to 40.27, marking an increase of 41.32.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.05 (Mar 24) to 0.00, marking a decrease of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.54. It has increased from 0.22 (Mar 24) to 0.54, marking an increase of 0.32.
• For Current Ratio (X), as of Mar 25, the value is 1.61. This value is within the healthy range. It has increased from 0.86 (Mar 24) to 1.61, marking an increase of 0.75.
• For Quick Ratio (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has increased from 0.40 (Mar 24) to 1.36, marking an increase of 0.96.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 4. It has increased from 0.11 (Mar 24) to 0.26, marking an increase of 0.15.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 83.50. This value is within the healthy range. It has increased from 18.55 (Mar 24) to 83.50, marking an increase of 64.95.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 59.08. This value is within the healthy range. It has increased from 15.99 (Mar 24) to 59.08, marking an increase of 43.09.
• For Enterprise Value (Cr.), as of Mar 25, the value is 348.67. It has decreased from 527.07 (Mar 24) to 348.67, marking a decrease of 178.40.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.75. This value is within the healthy range. It has decreased from 4.19 (Mar 24) to 1.75, marking a decrease of 2.44.
• For EV / EBITDA (X), as of Mar 25, the value is 7.91. This value is within the healthy range. It has decreased from 17.72 (Mar 24) to 7.91, marking a decrease of 9.81.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has decreased from 4.43 (Mar 24) to 1.89, marking a decrease of 2.54.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 1.71. This value is within the healthy range. It has decreased from 7.10 (Mar 24) to 1.71, marking a decrease of 5.39.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.89. This value is within the healthy range. It has decreased from 4.43 (Mar 24) to 1.89, marking a decrease of 2.54.
• For EarningsYield, as of Mar 25, the value is 0.32. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.32, marking an increase of 0.33.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness